Drugs / Peri
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03249285 | Mar 2016 → Mar 2018 | essential hypertension | Ospedale San Raffaele | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peri | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03249285 ↗ |
| Route | Oral | “Perindopril 4 mg /day, orally with titration to 8 mg/day after 1 month if BP (Blood pressure) is not controlled” NCT03249285 ↗ |